NCT04291001View on ClinicalTrials.gov

Ovarian Function With ENG Implant and UPA Use

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 4, 2020

Primary Completion Date

October 10, 2022

Study Completion Date

January 12, 2024

Conditions
Contraception
Interventions
DEVICE

ENG implant

This is an FDA-approved contraceptive device

DRUG

oral ulipristal acetate

This is an FDA-approved oral emergency contraceptive

Trial Locations (1)

84132

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Utah

OTHER

NCT04291001 - Ovarian Function With ENG Implant and UPA Use | Biotech Hunter | Biotech Hunter